Keyword: Christoph Schaffrath

Chemistry & Life Sciences

Expert Statement: Christoph Schaffrath, Lanxess

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Chemistry & Life Sciences

Saltigo at the BOS Forum

07.09.2011 - API Development - Changing demands and requirements in the design and implementation of work programs associated with both non-clinical and clinical phase development of novel APIs...